PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32331432-12	2020	Using a luciferase assay and western blot assay, we found that the NF-kappaB pathway was inhibited by Pg-EE, particularly by the decreased level of phosphorylated proteins of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) subunits (p65 and p50), inhibitor of kappa B alpha (IkappaBalpha), p85, and Src.	pg-ee	102-107	Rous sarcoma oncogene	Mus musculus	326-329	
32331432-13	2020	Using an overexpression strategy, cellular thermal shift assay, and immunoprecipitation analysis, we determined that the anti-inflammatory effect of Pg-EE was mediated by the inhibition of Src.	pg-ee	149-154	Rous sarcoma oncogene	Mus musculus	189-192	
32331432-15	2020	In conclusion, Pg-EE exerts anti-inflammatory activities by targeting Src in the NF-kappaB pathway, and these results suggest that Pg-EE could be used as an anti-inflammatory herbal medicine.	pg-ee	15-20	Rous sarcoma oncogene	Mus musculus	70-73	
32331432-15	2020	In conclusion, Pg-EE exerts anti-inflammatory activities by targeting Src in the NF-kappaB pathway, and these results suggest that Pg-EE could be used as an anti-inflammatory herbal medicine.	pg-ee	131-136	Rous sarcoma oncogene	Mus musculus	70-73